Business News • PR NewsWire • Tobira Therapeutics Highlights Data Presentations at the AASLD Annual Meeting Supporting its Phase 2b Program of Cenicriviroc for Nonalcoholic Steatohepatitis

Tobira Therapeutics Highlights Data Presentations at the AASLD Annual Meeting Supporting its Phase 2b Program of Cenicriviroc for Nonalcoholic Steatohepatitis

Tobira Therapeutics Highlights Data Presentations at the AASLD Annual Meeting Supporting its Phase 2b Program of Cenicriviroc for Nonalcoholic Steatohepatitis

SAN FRANCISCO, Nov. 8, 2014 /PRNewswire/ -- Tobira Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing cenicriviroc (CVC) in liver disease and HIV, announced today that it will be presenting two posters at "The Liver Meeting 2014," an annual international...

View More : http://www.prnewswire.com/news-releases/tobira-therapeutics-highlights-data-presentations-at-the-aasld-annual-meeting-su...

Releted News by prnewswire

Star Energy Partners™ CEO Tony Banks Speaks on Clean Power Plan Regulations

China-based Tian'an Cyber Park Group, In Tandem with Silicon Valley Leaders, Kicks Off the "Silicon Valley Express" Series of Sino-US Tech Exchange Meetings

Polyamide Market (PA) and Polyacetal Industry Trends and 2018 Forecasts